Pfizer CEO Albert Bourla and Accenture CEO Julie Sweet discuss how they’re using AI to transform their work. Watch the full ...
Tom Lanz (Senior Director, Multi-Omics and Biomarkers, Pfizer) explains how AI-powered multi-omics is improving drug safety.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results